Target intelligence / Profile preview

Carnitine O-palmitoyltransferase 1 (CPT1)

Target
CPT1
Molecular classification
Enzyme, Transferase, Acyltransferase
01

Overview

Carnitine O-palmitoyltransferase 1 (CPT1) is a mitochondrial enzyme crucial for the metabolism of long-chain fatty acids. It catalyzes the transfer of an acyl group from long-chain fatty acyl-CoA to L-carnitine, forming acyl-carnitines such as palmitoylcarnitine. This reaction is essential for transporting fatty acids into mitochondria for β-oxidation and energy production. CPT1 exists in three main isoforms in humans: CPT1A (Liver), CPT1B (Muscle), and CPT1C (Brain). CPT1 activity is tightly regulated, inhibited by malonyl-CoA, which links it directly to control by pathways involved in fatty acid synthesis versus oxidation. Mutations or deficiencies in CPT1 lead to carnitine palmitoyltransferase I deficiency, a rare metabolic disorder characterized by hypoketotic hypoglycemia during fasting or illness.

Other names
Carnitine palmitoyltransferase ICarnitine acyltransferase ICPTICAT1CoA:carnitine acyl transferase (CCAT)PalmitoylCoA transferase I
02

Mechanism of action

Catalyzes the transfer of an acyl group from long-chain fatty acyl-CoA to L-carnitine, facilitating transport of fatty acids into the mitochondria for beta-oxidation.

03

Biological functions

Fatty acid transportBeta-oxidationEnergy homeostasisLipid metabolism
04

Disease associations

Carnitine palmitoyltransferase I deficiencyHypoketotic hypoglycemiaHepatomegalyHepatic encephalopathy
05

Safety considerations

Risk of hypoketotic hypoglycemia during fasting or illnessPotential for life-threatening episodes if untreated in CPT1 deficiency
06

Interacting drugs

Malonyl-CoA (endogenous inhibitor)

Beyond the preview

Go deeper on Carnitine O-palmitoyltransferase 1 (CPT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carnitine O-palmitoyltransferase 1 (CPT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call